Key Points Glucocorticoids modulate growth hormone (GH) secretion at both the hypothalamic and pituitary level Hypoadrenalism might cause GH deficiency that is reversible during glucocorticoid replacement therapy Testing for GH deficiency in patients with hypopituitarism should always be performed after adequate periods of cortisol replacement Chronic excess of glucocorticoids, either exogenous or endogenous, causes GH deficiency that might be involved in metabolic and cardiovascular complications Treatment with recombinant GH could be considered in children and adults with glucocorticoid-induced GH deficiency This is a preview of subscription content, access via your institution Access options Subscribe to this journal Receive 12 print issues and online access $189.00 per year only $15.75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Intervention effects of okra extract on brain-gut peptides and intestinal microorganisms in sleep deprivation rats
Analysis of storage lipid accumulation in Alcanivorax borkumensis : evidence for alternative triacylglycerol biosynthesis routes in bacteria
Patients on clinical GHK-Cu protocols report improved skin texture and firmness, faster fading of pigmentation and minor scarring, and a fresher overall quality to their skin that tends to develop gradually over a full treatment cycle
Conclusion Keratosis Pilaris and acne may look similar at first glance, but they behave very differently
and microorganism like cyanobacteria, in attempt to improve the stress tolerance further and overcome the limitations of possessed by GSH in conferring growth and yield of plants (Semida et al., 2018